Lexicon Pharmaceuticals Files 8-K on Material Agreement
Ticker: LXRX · Form: 8-K · Filed: Jun 3, 2025
Sentiment: neutral
Topics: material-agreement, filing, corporate-action
Related Tickers: LXRP
TL;DR
Lexicon Pharma just filed an 8-K for a material definitive agreement - big news incoming!
AI Summary
On June 2, 2025, Lexicon Pharmaceuticals, Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes information regarding matters submitted to a vote of security holders and financial statements and exhibits.
Why It Matters
This 8-K filing signals a significant development for Lexicon Pharmaceuticals, likely involving a new contract or partnership that could impact its business operations and future growth.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that may affect the company's financial performance and stock price.
Key Players & Entities
- Lexicon Pharmaceuticals, Inc. (company) — Registrant
- June 2, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 2445 Technology Forest Blvd., 11th Floor The Woodlands , Texas 77381 (address) — Principal executive office address
FAQ
What is the nature of the material definitive agreement filed by Lexicon Pharmaceuticals?
The 8-K filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on June 2, 2025.
What other items are included in this 8-K filing besides the material definitive agreement?
The filing also includes information on matters submitted to a vote of security holders and financial statements and exhibits.
In which state is Lexicon Pharmaceuticals, Inc. incorporated?
Lexicon Pharmaceuticals, Inc. is incorporated in Delaware.
What is the principal executive office address for Lexicon Pharmaceuticals, Inc.?
The principal executive office address is 2445 Technology Forest Blvd., 11th Floor, The Woodlands, Texas 77381.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 3, 2025 regarding LEXICON PHARMACEUTICALS, INC. (LXRX).